196 related articles for article (PubMed ID: 25261069)
1. Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy.
Kishan AU; Wang PC; Sheng K; Yu V; Ruan D; Cao M; Tenn S; Low DA; Lee P
Technol Cancer Res Treat; 2015 Aug; 14(4):411-8. PubMed ID: 25261069
[TBL] [Abstract][Full Text] [Related]
2. Dose impact in radiographic lung injury following lung SBRT: Statistical analysis and geometric interpretation.
Yu V; Kishan AU; Cao M; Low D; Lee P; Ruan D
Med Phys; 2014 Mar; 41(3):031701. PubMed ID: 24593705
[TBL] [Abstract][Full Text] [Related]
3. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.
Palma DA; van Sörnsen de Koste J; Verbakel WF; Vincent A; Senan S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):974-8. PubMed ID: 20932655
[TBL] [Abstract][Full Text] [Related]
4. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
6. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
8. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
12. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
[TBL] [Abstract][Full Text] [Related]
13. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and radiation induced lung injury after thoracic stereotactic body radiotherapy.
Kalman NS; Hugo GD; Mahon RN; Deng X; Mukhopadhyay ND; Weiss E
Radiother Oncol; 2018 Nov; 129(2):270-276. PubMed ID: 30253874
[TBL] [Abstract][Full Text] [Related]
15. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
Pettersson N; Nyman J; Johansson KA
Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
[TBL] [Abstract][Full Text] [Related]
17. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
